Compare Shopify Inc. (SHOP) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shopify Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Shopify Inc. trades at $170.85 (market cap $211.73B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Shopify Inc. is far larger — about 12.5× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Shopify Inc. for 78 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| SHOP | ZBH | |
|---|---|---|
Market Cap | $211.73B | $16.95B |
Volume | 7,146,651 | 2,505,240 |
Sector | Technology | Health |
52-Week High | $179.01 | $103.98 |
52-Week Low | $95.40 | $79.58 |
Typical Hold Time | 78 Days | 89 Days |
Enterprise Value | $206.96B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Shopify trades at $164.54, down 0.84% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust revenue growth, increasing from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 111.19. Recent developments include the launch of Canvas AI store builder and strategic moves in AI-powered commerce positioning.
Outlook remains positive with 67% analyst buy ratings and $168.63 consensus target, though high valuation and competitive pressures from Amazon present risks. Operating cash flow growth to $2.4B projected for 2026 supports continued investment in merchant solutions and AI capabilities.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
